Cambridge Investment Research Advisors, Inc. Corcept Therapeutics Inc Transaction History
Cambridge Investment Research Advisors, Inc.
- $29.9 Billion
- Q4 2024
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 19,766 shares of CORT stock, worth $1.23 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,766
Previous 26,855
26.4%
Holding current value
$1.23 Million
Previous $1.24 Million
19.87%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding CORT
# of Institutions
414Shares Held
84.9MCall Options Held
1.04MPut Options Held
1.33M-
Black Rock Inc. New York, NY16.5MShares$1.03 Billion0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$630 Million0.01% of portfolio
-
Ingalls & Snyder LLC New York, NY8.1MShares$504 Million16.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.2MShares$386 Million0.49% of portfolio
-
Parallel Advisors, LLC3.97MShares$247 Million5.04% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $6.67B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...